With regards to the subgroup analysis on romiplostim, the lack of statistical significance (p > 0.05) between the platelet count increase in romiplostim and non-romiplostim TPO-RA may be attributed to the difference in starting thrombocytopenia grades/platelet count. This evidence concerns the gene TPO and Thrombocytopenia.